Results 1 to 10 of about 141,414 (265)
This article reviews methotrexate and the more potent, related compound, pralatrexate, for the treatment of cutaneous T-cell lymphomas, including mycosis fungoides, Sézary syndrome, and CD30+ lymphoproliferative disorders. Although these folate antagonists are traditionally viewed as antiproliferative cell cycle inhibitors, it is recognized that they ...
Wood, Gary S., Wu, Jianqiang
openaire +2 more sources
The pharmacogenetics of methotrexate [PDF]
Methotrexate (MTX) is a cornerstone of therapy for rheumatoid arthritis. However, it is not universally effective and up to one-third of patients fail to respond to treatment, either because of inefficacy or adverse events, although at present it is not possible to predict therapy response accurately.
S L, Hider, I N, Bruce, W, Thomson
openaire +2 more sources
Background Ectopic pregnancy (EP) can be treated surgically or nonsurgically. In many countries, methotrexate is frequently used as a first-line medical treatment, and its effect is similar to that of surgery in selected patients. We aimed to investigate
Risa Ishida +7 more
doaj +1 more source
Background To evaluate the effects of systemic methotrexate in cesarean scar pregnancy (CSP) patients treated with ultrasound-guided suction curettage. Methods A retrospective review of all women presenting with CSP treated with ultrasound-guided suction
Sheng Wang +3 more
doaj +1 more source
The Study of Results of Liver Biopsy in Psoriatic Patients Which Treated by Methotrexate
Objective: To assess Methotrexate-related side effects on the liver. Patients & methods: 45 liver biopsies were examined in dermatology ward of Loghman-e-Hakim Hospital in 1986-91.27 liver biopsies were examined after treatment with Methotrexate and ...
Shora Manighalam +2 more
doaj
High-dose methotrexate is a cornerstone agent in the chemotherapeutic treatment of patients with osteosarcoma. However, patients often develop methotrexate-induced toxicities.
Evelien G. E. Hurkmans +10 more
doaj +1 more source
Background This case report and literature review present two instances of delayed methotrexate clearance in individuals who were successfully managed using fixed dosing versus weight-based dosing of glucarpidase.
John Grofvert +4 more
doaj +1 more source
Biologic therapy with anti-TNFa in rheumathoid atrhritis
Objective: To evaluate the efficacy, the tolerability, and treatment survival of the association of anti-TNFa (Infliximab, Etanercept, Adalimumab) plus Methotrexate vs Methotrexate as monotherapy in patients with reumathoid arthritis (RA).
G. Ferraccioli
doaj +1 more source
Mentor: Bryant R. England Program: Internal Medicine, Division of Rheumatology Type: Original Research Background: Rheumatoid arthritis (RA) patients are at increased risk of cardiovascular disease (CVD). Methotrexate, a mainstay in RA treatment, appears
Tate Johnson +7 more
doaj +1 more source
CONTEXT: Methotrexate and other anticancer agents can induce intestinal mucositis, which is one of the most common limiting factor that prevent further dose escalation of the methotrexate. OBJECTIVES: To evaluate the gastric emptying and gastrointestinal
Pedro M. G. Soares +5 more
doaj +1 more source

